Neonatal asphyxia
Asphyxia of the newborn refers to a disease in which the baby suffers from intrauterine distress or respiratory and circulatory disorders caused by various causes before, during or after birth, resulting in no spontaneous breathing or failure to establish regular breathing within 1 minute after birth, with hypoxemia, hypercapnia and acidosis as the main pathological and physiological changes. It is the most common symptom of newborns, mostly a continuation of fetal asphyxia (intrauterine distress), and is also one of the main causes of disability and death. Rescue and care are needed every second.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Newborns -
Related symptoms:
Pale skin Slow and shallow breathing Respiratory depression Neonatal heart failure Blue complexion -
Concurrent disease:
Related Drugs
Lobeline Hydrochloride Injection
Indication: This product is mainly used for central respiratory depression caused by various reasons. It is commonly used clinically for neonatal asphyxia, carbon monoxide, opioid poisoning, etc.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Lobeline Hydrochloride Injection
Indication: This product is mainly used for central respiratory depression caused by various reasons. It is commonly used clinically for neonatal asphyxia, carbon monoxide, opioid poisoning, etc.
Manufacturer:
Shandong Huicheng Pharmaceutical Co., Ltd.
Lobeline Hydrochloride Injection
Indication: This product is mainly used for central respiratory depression caused by various reasons. It is commonly used clinically for neonatal asphyxia, carbon monoxide, opioid poisoning, etc.
Lobeline Hydrochloride Injection
Indication: This product is mainly used for central respiratory depression caused by various reasons. It is commonly used clinically for neonatal asphyxia, carbon monoxide, opioid poisoning, etc.
Lobeline Hydrochloride Injection
Indication: This product is mainly used for central respiratory depression caused by various reasons. It is commonly used clinically for neonatal asphyxia, carbon monoxide, opioid poisoning, etc.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Cytochrome C Injection
Indication: Used as an auxiliary treatment for emergency treatment of various tissue hypoxia, such as carbon monoxide poisoning, hypnotic poisoning, cyanide poisoning, neonatal asphyxia, severe shock period hypoxia, cerebrovascular accident, sequelae of concussion, dyspnea caused by anesthesia and lung diseases, and treatment of myocardial hypoxia caused by various heart diseases.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Cytochrome C Injection
Indication: Used as an auxiliary treatment for emergency treatment of various tissue hypoxia, such as carbon monoxide poisoning, hypnotic poisoning, cyanide poisoning, neonatal asphyxia, severe shock period hypoxia, cerebrovascular accident, sequelae of concussion, dyspnea caused by anesthesia and lung diseases, and treatment of myocardial hypoxia caused by various heart diseases.
Manufacturer:
Anhui Golden Sun Biochemical Pharmaceutical Co., Ltd.
Cytochrome C Injection
Indication: Used as an auxiliary treatment for emergency treatment of various tissue hypoxia, such as carbon monoxide poisoning, hypnotic poisoning, cyanide poisoning, neonatal asphyxia, severe shock period hypoxia, cerebrovascular accident, sequelae of concussion, dyspnea caused by anesthesia and lung diseases, and treatment of myocardial hypoxia caused by various heart diseases.
Manufacturer:
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Cytochrome C Injection
Indication: Used as an auxiliary treatment for emergency treatment of various tissue hypoxia, such as carbon monoxide poisoning, hypnotic poisoning, cyanide poisoning, neonatal asphyxia, severe shock period hypoxia, cerebrovascular accident, sequelae of concussion, dyspnea caused by anesthesia and lung diseases, and treatment of myocardial hypoxia caused by various heart diseases.
Manufacturer:
Duoduo Pharmaceutical Co., Ltd.
Cytochrome C Injection
Indication: Used as an auxiliary treatment for emergency treatment of various tissue hypoxia, such as carbon monoxide poisoning, hypnotic poisoning, cyanide poisoning, neonatal asphyxia, severe shock period hypoxia, cerebrovascular accident, sequelae of concussion, dyspnea caused by anesthesia and lung diseases, and treatment of myocardial hypoxia caused by various heart diseases.
Manufacturer:
Wuhan Changlian Laifu Pharmaceutical Co., Ltd.
Related Ingredients
-
alpha-Lobeline hydrochloride list
134-63-4 -
Cytochrome C list
9007-43-6